Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
All content for Footprints & Impacts Podcast is the property of EHAC-ASEC and ASEQ-EHAQ and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
La SCM et les droits humains : occasions manquées et chemin à parcourir avec Me Paul-Claude Bérubé
Footprints & Impacts Podcast
45 minutes
1 month ago
La SCM et les droits humains : occasions manquées et chemin à parcourir avec Me Paul-Claude Bérubé
Send us a text La SCM et les droits humains : occasions manquées et chemin à parcourir. Pourquoi la Sensibilité Chimique Multiple (SCM), une condition médicale pour laquelle plus d’un million de Canadiens ont reçu un diagnostic, reste-t-elle marginalisée par rapport aux autres handicaps? Et que faudra-t-il pour obtenir enfin reconnaissance, droits et justice? Dans cet épisode d'Empreintes & Impacts, nous recevons Me Paul-Claude Bérubé, nouveau directeur général de la COPHAN et ardent dé...
Footprints & Impacts Podcast
Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
